About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Philadelphia | 157 Studies

Clinical Trials Alzheimer's DiseasePhiladelphia

Alzheimer's Disease Clinical Trials in Philadelphia

Find 157 clinical trials for alzheimer's disease near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 157 trials

CompletedTau Imaging in Young Onset DementiaThe central goal of this study is to determine and compare the similarities and differences in regional brain uptake of \[18F\]T807 in patients with typical Alzheimer's Disease…NCT02289118·Philadelphia, Pennsylvania CompletedStudy of Melatonin: Sleep Problems in Alzheimer's DiseaseThis protocol is a multicenter clinical trial of melatonin for sleep disturbances associated with Alzheimer's disease (AD).NCT00000171·Tucson, Arizona and 30 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedCare of Persons With Dementia in Their Environments (COPE) in Programs of All-Inclusive Care of the Elderly (PACE)The protocol is organized into three Phases - In Phase I an online training program will be developed in "Care of Persons with Dementia in their Environments" (COPE) -an…NCT04165213·Philadelphia, Pennsylvania

RecruitingUsing the EHR to Advance Genomic Medicine Across a Diverse Health SystemGiven the expansion of indications for genetic testing and our understanding of conditions for which the results change medical management, it is imperative to consider novel ways…NCT06377033·Philadelphia, Pennsylvania

Active not recruitingA Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's DiseaseThis is a Phase 2, double-blind, parallel-group, placebo-controlled study to assess safety, tolerability, pharmacokinetics, and efficacy of ONO-2020 in participants with mild to…NCT06881836·Phoenix, Arizona and 79 others

CompletedEfficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to determine the efficacy of ramelteon, once daily (QD), in subjects with mild to moderate Alzheimer's Disease and sleep disturbanceNCT00325728·Alabaster, Alabama and 71 others

CompletedRisk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)This study is intended to examine the impact of learning amyloid brain imaging results among asymptomatic older adults, and how to safely communicate these results and educate on…NCT02959489·Boston, Massachusetts and 3 others

CompletedTelesupport: Evaluation of Professionally Led Support Groups for CaregiversThis study is a collaborative effort between a community-based service organization, Supportive Older Women's Network (SOWN), and an academic research division at Thomas Jefferson…NCT00259415·Philadelphia, Pennsylvania

CompletedFeasibility of the SmartPrompt for Improving Everyday Function in DementiaDifficulty completing everyday tasks is a primary reason for the high cost of care, loss of caregiver paid hours, and general caregiver burden associated with dementia.NCT04313582·Philadelphia, Pennsylvania

RecruitingStudy of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183AThe current protocol is to determine the biodistribution, metabolism, excretion and brain uptake of 18F-JSS20-183A.NCT06932809·San Francisco, California and 1 other

CompletedEffects of LY450139, on the Progression of Alzheimer's Disease as Compared With PlaceboAlzheimer's disease (AD) is a fatal degenerative disease of the brain for which there is no cure. AD causes brain cells to die.NCT00762411·Phoenix, Arizona and 90 others

CompletedDepression in Alzheimer's Disease-2The purpose of this study is to learn whether treating individuals with Alzheimer's disease and depression with the anti-depressant medication sertraline (Zoloft) is helpful to…NCT00086138·Los Angeles, California and 4 others

CompletedAlzheimer's Disease Neuroimaging Initiative 3Since its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) has been realized in informing the design of therapeutic trials in AD.NCT02854033·Birmingham, Alabama and 58 others

CompletedThe STEP 4Life TrialThe objective of this study is to test the feasibility of using behavioral economic interventions (gamification with social incentives) targeting daily step counts to prevent or…NCT05069155·Philadelphia, Pennsylvania

CompletedFollow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05This study will evaluate longitudinal change of tau deposition as measured by flortaucipir F 18 uptake over time.NCT02795780·Phoenix, Arizona and 21 others

CompletedProject ACT: Advancing Caregiving TechniquesThe specific aims of this study are to: 1. Test the immediate effectiveness of the intervention to reduce caregiver upset with targeted disruptive behaviors (primary outcome).NCT00259480·Philadelphia, Pennsylvania

RecruitingUPenn Observational Research Repository on Neurodegenerative DiseaseThe aim of this study is to create a repository of both cross-sectional and longitudinal data, including cognitive, linguistic, imaging and biofluid biological specimens, for…NCT04715399·Philadelphia, Pennsylvania

CompletedCoordinating Center for Caregiver Intervention TrialThe primary goal of this study is to test a single multi-component intervention among family caregivers of persons with Alzheimer's disease or related disorders.NCT00177489·Birmingham, Alabama and 4 others

CompletedStudy Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET StudyThis study seeks to confirm a demonstrated treatment effect of intepirdine (RVT-101) as an adjunctive therapy to donepezil for the treatment of subjects with Alzheimer's disease.NCT02585934·Phoenix, Arizona and 196 others

CompletedEARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)12-week, open-label study to evaluate the effectiveness and safety of donepezil hydrochloride in Hispanic patients with mild to moderate Alzheimer's Disease (AD) in the U.S.NCT00230568·Phoenix, Arizona and 34 others

PreviousPage 5 of 8Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia